Nicole Rothman
Family · Durham, NCNPI 1528507704
Payments from drug & device makers
Across 854 payments — averaging $313.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$247K
- Biohaven Pharmaceuticals, Inc.$8K
- Biohaven Pharmaceutical Holding Company Ltd.$5K
- Teva Pharmaceuticals USA, Inc.$2K
- Pfizer$2K
- Lundbeck LLC$1K
- plus $4K from 21 others
What the payments were for
- Consulting fees$3,8601%
- Speaking & faculty fees$237,91489%
- Travel & lodging$13,1345%
- Food & beverage$12,7905%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 514 | $246,941 |
| Biohaven Pharmaceuticals, Inc. | 26 | $7,559 |
| Biohaven Pharmaceutical Holding Company Ltd. | 20 | $4,508 |
| Teva Pharmaceuticals USA, Inc. | 34 | $2,068 |
| Pfizer | 39 | $1,519 |
| Lundbeck LLC | 31 | $1,347 |
| Amgen | 35 | $812 |
| Lilly USA, LLC | 29 | $596 |
| Impel Pharmaceuticals Inc. | 23 | $447 |
| Impel Pharmaceuticals LLC | 20 | $424 |
| Upsher-smith Laboratories LLC | 19 | $338 |
| Axsome Therapeutics, Inc. | 4 | $182 |
| Merz Pharmaceuticals, LLC | 6 | $154 |
| Almatica Pharma LLC | 17 | $123 |
| Collegium Pharmaceutical, Inc. | 5 | $112 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Idorsia Pharmaceuticals US Inc | 6 | $92 |
| Tonix Medicines, Inc. | 3 | $83 |
| Jazz Pharmaceuticals Inc. | 4 | $76 |
| Merck | 5 | $72 |
| Scilex Pharmaceuticals Inc. | 2 | $40 |
| Eisai Inc. | 2 | $35 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
| Virtus Pharmaceuticals LLC | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| MDD US Operations, LLC | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$267,715 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 114 | $162,141 |
| QuliptaAtogepant | 106 | $127,227 |
| Nurtec OdtRimegepant Sulfate | 90 | $112,454 |
| BotoxOnabotulinumtoxina | 68 | $87,911 |
| Emgality SyringeGalcanezumab-Gnlm | 37 | $56,859 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 23 | $48,904 |
| Aimovig AutoinjectorErenumab-Aooe | 52 | $45,752 |
| Ajovy SyringeFremanezumab-Vfrm | 41 | $39,916 |
| Emgality PenGalcanezumab-Gnlm | 54 | $38,017 |
| ReyvowLasmiditan Succinate | 43 | $32,655 |
| Zembrace SymtouchSumatriptan Succinate | 11 | $16,553 |
| Sumatriptan Succinate | 59 | $6,024 |
| BelsomraSuvorexant | 13 | $5,404 |
| Carbidopa | 13 | $3,055 |
| Gabapentin | 65 | $1,068 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta, Botox | $246,941 | $377,279288 claims |
| PfizerNurtec Odt | $1,519 | $112,45490 claims |
| Lilly USA, LLCReyvow | $596 | $32,65543 claims |
| Upsher-smith Laboratories LLCZembrace Symtouch, Topiramate | $338 | $16,92658 claims |
| MerckBelsomra | $72 | $5,40413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.
Other family in Durham
- Juanita PerkinsDurham$213K
- Melissa LamirandDurham$68K
- Amanda RidenhourDurham$13K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.